OGFR and sensorineural hearing loss disorder: Specifically, elevated LATS1 (OR = 1.81; 95% CI, 1.39–2.38; p = 0.006) and LMNB2 (OR = 2.33; 95% CI, 1.55–3.51; p = 0.011) increased the risk of SNHL, whereas increased TEF (OR = 0.60; 95% CI, 0.47–0.78; p = 0.006), OGFR (OR = 0.65; 95% CI, 0.53–0.82; p = 0.027), and EIF2AK3 (OR = 0.77; 95% CI, 0.67–0.89; p = 0.048) decreased the risk of SNHL (Table 1 and Figure 2A).